PLCB3 and colorectal carcinoma: With a hazard ratio (HR) of 2.75 and a confidence interval (CI) ranging from 1.61 to 4.68, PLCB3 exerts the most pronounced impact on the outcomes of colorectal cancer (CRC) patients.